Earnings Per Share, Basic of VERTEX PHARMACEUTICALS INC / MA from 31 Mar 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Mar 2010 to 30 Sep 2025.
  • VERTEX PHARMACEUTICALS INC / MA Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was 4.24, a 4.7% increase year-over-year.
  • VERTEX PHARMACEUTICALS INC / MA Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 14.
  • VERTEX PHARMACEUTICALS INC / MA annual Earnings Per Share, Basic for 2024 was -2.08, a 115% decline from 2023.
  • VERTEX PHARMACEUTICALS INC / MA annual Earnings Per Share, Basic for 2023 was 14.05, a 8.3% increase from 2022.
  • VERTEX PHARMACEUTICALS INC / MA annual Earnings Per Share, Basic for 2022 was 12.97, a 43% increase from 2021.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 14 4.24 +0.19 +4.7% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 14 4.02 +17.94 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 -3 2.52 -1.74 -41% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 -2 3.53 -0.24 -6.4% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
Q3 2024 -1 4.05 +0.04 +1% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 -1 -13.92 -17.47 -492% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 15 4.26 +1.54 +57% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 14 3.77 +0.59 +19% 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 13 4.01 +0.38 +10% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 13 3.55 +0.38 +12% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 12 2.72 -0.27 -9% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 12 3.18 +0.17 +5.6% 01 Oct 2022 31 Dec 2022 10-K 13 Feb 2025 2024 FY
Q3 2022 12 3.63 +0.33 +10% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 12 3.17 +2.91 +1119% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 9 2.99 +0.47 +19% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q4 2021 9 3.01 +0.69 +30% 01 Oct 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
Q3 2021 8 3.3 +0.74 +29% 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022 2022 Q3
Q2 2021 7 0.26 -2.96 -92% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 10 2.52 +0.2 +8.6% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 10 2.32 +0.06 +2.7% 01 Oct 2020 31 Dec 2020 10-K 11 Feb 2021 2020 FY
Q3 2020 10 2.56 +2.34 +1064% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 8 3.22 +2.18 +210% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 5 2.32 +1.27 +121% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q4 2019 4 2.26 -3.82 -63% 01 Oct 2019 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q3 2019 8 0.22 -0.29 -57% 01 Jul 2019 30 Sep 2019 10-K 11 Feb 2021 2020 FY
Q2 2019 8 1.04 +0.22 +27% 01 Apr 2019 30 Jun 2019 10-K 11 Feb 2021 2020 FY
Q1 2019 8 1.05 +0.22 +27% 01 Jan 2019 31 Mar 2019 10-K 11 Feb 2021 2020 FY
Q4 2018 8 6.08 +5.68 +1420% 01 Oct 2018 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q3 2018 2 0.51 +0.92 01 Jul 2018 30 Sep 2018 10-K 13 Feb 2020 2019 FY
Q2 2018 1 0.82 +0.75 +1071% 01 Apr 2018 30 Jun 2018 10-K 13 Feb 2020 2019 FY
Q1 2018 0 0.83 -0.18 -18% 01 Jan 2018 31 Mar 2018 10-K 13 Feb 2020 2019 FY
Q4 2017 1 0.4 +0.27 +208% 01 Oct 2017 31 Dec 2017 10-K 13 Feb 2019 2018 FY
Q3 2017 0 -0.41 -0.25 -156% 01 Jul 2017 30 Sep 2017 10-K 13 Feb 2019 2018 FY
Q2 2017 1 0.07 +0.33 01 Apr 2017 30 Jun 2017 10-K 13 Feb 2019 2018 FY
Q1 2017 0 1.01 +1.18 01 Jan 2017 31 Mar 2017 10-K 13 Feb 2019 2018 FY
Q4 2016 0 0.13 +0.44 01 Oct 2016 31 Dec 2016 10-K 15 Feb 2018 2017 FY
Q3 2016 0 -0.16 +0.23 +59% 01 Jul 2016 30 Sep 2016 10-K 15 Feb 2018 2017 FY
Q2 2016 -1 -0.26 +0.52 +67% 01 Apr 2016 30 Jun 2016 10-K 15 Feb 2018 2017 FY
Q1 2016 -1 -0.17 +0.66 +80% 01 Jan 2016 31 Mar 2016 10-K 15 Feb 2018 2017 FY
Q4 2015 -2 -0.31 +0.43 +58% 01 Oct 2015 31 Dec 2015 10-K 15 Feb 2018 2017 FY
Q3 2015 -2 -0.39 +0.33 +46% 01 Jul 2015 30 Sep 2015 10-Q 31 Oct 2016 2016 Q3
Q2 2015 -3 -0.78 -0.1 -15% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016 2016 Q2
Q1 2015 -2 -0.83 +0.17 +17% 01 Jan 2015 31 Mar 2015 10-Q 03 May 2016 2016 Q1
Q4 2014 -3 -0.74 -0.93 -489% 01 Oct 2014 31 Dec 2014 10-K 23 Feb 2017 2016 FY
Q3 2014 -2 -0.72 -0.18 -33% 01 Jul 2014 30 Sep 2014 10-Q 30 Oct 2015 2015 Q3
Q2 2014 -2 -0.68 -0.42 -162% 01 Apr 2014 30 Jun 2014 10-Q 04 Aug 2015 2015 Q2
Q1 2014 -1 -1 +0.43 +30% 01 Jan 2014 31 Mar 2014 10-Q 04 May 2015 2015 Q1
Q4 2013 -2 0.19 +0.54 01 Oct 2013 31 Dec 2013 10-K 11 Feb 2014 2013 FY
Q3 2013 -2 -0.54 -0.27 -100% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2014 Q3
Q2 2013 -2 -0.26 +0.05 +16% 01 Apr 2013 30 Jun 2013 10-Q 31 Jul 2014 2014 Q2
Q1 2013 -2 -1.43 -1.87 -425% 01 Jan 2013 31 Mar 2013 10-Q 05 May 2014 2014 Q1
Q4 2012 0 -0.35 -1.11 -146% 01 Oct 2012 31 Dec 2012 10-K 11 Feb 2014 2013 FY
Q3 2012 0 -0.27 -1.33 -125% 01 Jul 2012 30 Sep 2012 10-K 11 Feb 2014 2013 FY
Q2 2012 1 -0.31 +0.54 +64% 01 Apr 2012 30 Jun 2012 10-K 11 Feb 2014 2013 FY
Q1 2012 1 0.44 +1.31 01 Jan 2012 31 Mar 2012 10-K 11 Feb 2014 2013 FY
Q4 2011 0 0.76 +1.66 01 Oct 2011 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 -1 1.06 +2.1 01 Jul 2011 30 Sep 2011 10-K 01 Mar 2013 2012 FY
Q2 2011 -3 -0.85 +0.15 +15% 01 Apr 2011 30 Jun 2011 10-K 01 Mar 2013 2012 FY
Q1 2011 -3 -0.87 -0.04 -4.8% 01 Jan 2011 31 Mar 2011 10-K 01 Mar 2013 2012 FY
Q4 2010 -3 -0.9 01 Oct 2010 31 Dec 2010 10-K 22 Feb 2012 2011 FY
Q3 2010 -1.04 01 Jul 2010 30 Sep 2010 10-K 22 Feb 2012 2011 FY
Q2 2010 -1 01 Apr 2010 30 Jun 2010 10-K 22 Feb 2012 2011 FY
Q1 2010 -0.83 01 Jan 2010 31 Mar 2010 10-K 22 Feb 2012 2011 FY

VERTEX PHARMACEUTICALS INC / MA Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 -2.08 -16.13 -115% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
2023 14.05 +1.08 +8.3% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
2022 12.97 +3.88 +43% 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025 2024 FY
2021 9.09 -1.35 -13% 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
2020 10.44 +5.86 +128% 01 Jan 2020 31 Dec 2020 10-K 10 Feb 2023 2022 FY
2019 4.58 -3.66 -44% 01 Jan 2019 31 Dec 2019 10-K 09 Feb 2022 2021 FY
2018 8.24 +7.18 +677% 01 Jan 2018 31 Dec 2018 10-K 11 Feb 2021 2020 FY
2017 1.06 +1.52 01 Jan 2017 31 Dec 2017 10-K 13 Feb 2020 2019 FY
2016 -0.46 +1.85 +80% 01 Jan 2016 31 Dec 2016 10-K 13 Feb 2019 2018 FY
2015 -2.31 +0.83 +26% 01 Jan 2015 31 Dec 2015 10-K 15 Feb 2018 2017 FY
2014 -3.14 -1.16 -59% 01 Jan 2014 31 Dec 2014 10-K 23 Feb 2017 2016 FY
2013 -1.98 -1.48 -296% 01 Jan 2013 31 Dec 2013 10-K 16 Feb 2016 2015 FY
2012 -0.5 -0.64 -457% 01 Jan 2012 31 Dec 2012 10-K 13 Feb 2015 2014 FY
2011 0.14 +3.91 01 Jan 2011 31 Dec 2011 10-K 11 Feb 2014 2013 FY
2010 -3.77 01 Jan 2010 31 Dec 2010 10-K 01 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.